Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 12676 | 888 | 26.4 | 31% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 522 | 3 | MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM | 20526 |
| 878 | 2 | NEBIVOLOL//CARVEDILOL//BETA BLOCKERS | 11463 |
| 12676 | 1 | AMOSULALOL//DILEVALOL//AARHUS CTY HOSP MED 1 | 888 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | AMOSULALOL | authKW | 110031 | 0% | 80% | 4 |
| 2 | DILEVALOL | authKW | 99102 | 1% | 41% | 7 |
| 3 | AARHUS CTY HOSP MED 1 | address | 34385 | 0% | 100% | 1 |
| 4 | ALPHA AND BETA ADRENOCEPTOR ANTAGONIST | authKW | 34385 | 0% | 100% | 1 |
| 5 | ALPHA BLOCKER AND BETA BLOCKER | authKW | 34385 | 0% | 100% | 1 |
| 6 | AROTINOLOL ENANTIOMERS | authKW | 34385 | 0% | 100% | 1 |
| 7 | ATENOLOL ATENOLOL AND ATENOLOL | authKW | 34385 | 0% | 100% | 1 |
| 8 | BETA1 ADRENOCEPTORS AND BETA2 ADRENOCEPTORS | authKW | 34385 | 0% | 100% | 1 |
| 9 | CAS 75659 07 3 | authKW | 34385 | 0% | 100% | 1 |
| 10 | CAT ISOLATED ARTERY | authKW | 34385 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 8327 | 56% | 0% | 498 |
| 2 | Cardiac & Cardiovascular System | 1489 | 17% | 0% | 151 |
| 3 | Medicine, General & Internal | 1091 | 17% | 0% | 154 |
| 4 | Medicine, Research & Experimental | 295 | 8% | 0% | 70 |
| 5 | Chemistry, Medicinal | 125 | 4% | 0% | 38 |
| 6 | Peripheral Vascular Diseases | 83 | 4% | 0% | 32 |
| 7 | Toxicology | 72 | 3% | 0% | 31 |
| 8 | Chemistry, Analytical | 35 | 4% | 0% | 38 |
| 9 | Medical Laboratory Technology | 5 | 1% | 0% | 6 |
| 10 | Biochemical Research Methods | 3 | 2% | 0% | 15 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | AARHUS CTY HOSP MED 1 | 34385 | 0% | 100% | 1 |
| 2 | MED 80 E CONCORD ST | 34385 | 0% | 100% | 1 |
| 3 | MED HYPERTENS SECT | 34385 | 0% | 100% | 1 |
| 4 | PUKO | 34385 | 0% | 100% | 1 |
| 5 | SHANGHAI HOSP AFFILIATED 5 | 34385 | 0% | 100% | 1 |
| 6 | SHANGHAI PHAMACEUT METABOL | 34385 | 0% | 100% | 1 |
| 7 | OSTRA HOSP CLIN PHYSIOL | 6875 | 0% | 20% | 1 |
| 8 | MBC 03 | 4296 | 0% | 13% | 1 |
| 9 | CLIN PHARMACOL CARDIOL | 3437 | 0% | 10% | 1 |
| 10 | CARDIOVASC PHARMACOL GRP | 2021 | 0% | 6% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 21344 | 8% | 1% | 71 |
| 2 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 10883 | 4% | 1% | 39 |
| 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 9413 | 6% | 1% | 55 |
| 4 | CLINICAL TRIALS JOURNAL | 7828 | 1% | 3% | 9 |
| 5 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 5918 | 4% | 0% | 35 |
| 6 | ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 5470 | 2% | 1% | 19 |
| 7 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 5276 | 3% | 1% | 30 |
| 8 | JOURNAL OF CLINICAL PHARMACOLOGY | 4246 | 3% | 0% | 26 |
| 9 | JOURNAL OF AUTONOMIC PHARMACOLOGY | 4079 | 1% | 1% | 10 |
| 10 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 3502 | 2% | 1% | 20 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | GOA, KL , BENFIELD, P , SORKIN, EM , (1989) LABETALOL - A REAPPRAISAL OF ITS PHARMACOLOGY, PHARMACOKINETICS AND THERAPEUTIC USE IN HYPERTENSION AND ISCHEMIC HEART-DISEASE.DRUGS. VOL. 37. ISSUE 5. P. 583-627 | 102 | 63% | 31 |
| 2 | MACCARTHY, EP , BLOOMFIELD, SS , (1983) LABETALOL - A REVIEW OF ITS PHARMACOLOGY, PHARMACOKINETICS, CLINICAL USES AND ADVERSE-EFFECTS.PHARMACOTHERAPY. VOL. 3. ISSUE 4. P. 193-219 | 82 | 78% | 64 |
| 3 | YUZHAKOV, SD , MASHKOVSKY, MD , (1986) BETA-ADRENOBLOCKERS POSSESSING ALPHA-ADRENOBLOCKING AND VASODILATIVE ACTIVITY.KHIMIKO-FARMATSEVTICHESKII ZHURNAL. VOL. 20. ISSUE 8. P. 918-928 | 44 | 86% | 0 |
| 4 | CHRISP, P , GOA, KL , (1990) DILEVALOL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN HYPERTENSION.DRUGS. VOL. 39. ISSUE 2. P. 234-263 | 32 | 82% | 11 |
| 5 | KANTO, JH , (1985) CURRENT STATUS OF LABETALOL, THE 1ST ALPHA-BLOCKING AND BETA-BLOCKING AGENT.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 23. ISSUE 11. P. 617-628 | 44 | 77% | 18 |
| 6 | LALONDE, RL , TENERO, DM , KAZIERAD, DJ , (1990) DILEVALOL - AN OVERVIEW OF ITS CLINICAL-PHARMACOLOGY AND THERAPEUTIC USE IN HYPERTENSION.PHARMACOTHERAPY. VOL. 10. ISSUE 1. P. 15-28 | 28 | 85% | 5 |
| 7 | CARTER, BL , (1983) LABETALOL (TRANDATE, GLAXO-INC - NORMODYNE, SCHERING-CORP).DRUG INTELLIGENCE & CLINICAL PHARMACY. VOL. 17. ISSUE 10. P. 704-712 | 39 | 87% | 6 |
| 8 | DONNELLY, R , MACPHEE, GJA , (1991) CLINICAL PHARMACOKINETICS AND KINETIC-DYNAMIC RELATIONSHIPS OF DILEVALOL AND LABETALOL.CLINICAL PHARMACOKINETICS. VOL. 21. ISSUE 2. P. 95-109 | 28 | 64% | 8 |
| 9 | GRELLET, J , MICHELGUEROULT, P , DUCINT, D , SAUX, MC , (1994) SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF LABETALOL DIASTEREOISOMERS IN PLASMA SAMPLES WITHOUT DERIVATIZATION.JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS. VOL. 652. ISSUE 1. P. 59-66 | 18 | 86% | 4 |
| 10 | PRICHARD, BNC , (1984) COMBINED ALPHA-RECEPTOR AND BETA-RECEPTOR INHIBITION IN THE TREATMENT OF HYPERTENSION.DRUGS. VOL. 28. ISSUE . P. 51-68 | 38 | 66% | 17 |
Classes with closest relation at Level 1 |